SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (1841)10/16/2000 7:50:51 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 52153
 
All thoughts welcome? Why not go to V*lentis and see what they plan to do with the acquired PolyM*SC? You'll find out what one potential competitor thinks about the competitive situation and opportunities.

I'm curious from this angle..... with talk of producing therapeutic proteins in plants, will PEGylation IP go through the future roof, valuation speaking.